AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹2,299 Cr | ₹1,692 Cr | ₹1,515 Cr | ₹1,058 Cr | ₹1,066 Cr |
What is the latest Short Term Loans and Advances ratio of AUROBINDO PHARMA ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹2,299 Cr |
Mar2023 | ₹1,692 Cr |
Mar2022 | ₹1,515 Cr |
Mar2021 | ₹1,058 Cr |
Mar2020 | ₹1,066 Cr |
How is Short Term Loans and Advances of AUROBINDO PHARMA Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹2,299 Cr | 35.82 | |
Mar2023 | ₹1,692 Cr | 11.73 | |
Mar2022 | ₹1,515 Cr | 43.12 | |
Mar2021 | ₹1,058 Cr | -0.72 | |
Mar2020 | ₹1,066 Cr | - |
Compare Short Term Loans and Advances of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹64,439.8 Cr | -2.3% | -4.8% | -8.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,076.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -2.3% |
-4.8% |
-8.4% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses